This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Golomb, Harvey M.
| Item Type | Name |
|
Concept
|
Carcinoma, Small Cell
|
|
Academic Article
|
Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).
|
|
Academic Article
|
Adriamycin-radiotherapy interaction.
|
|
Academic Article
|
Lung cancer: A combined modality approach to staging and therapy.
|
|
Academic Article
|
Letter: Combined therapy for small-cell carcinoma of the bronchus.
|
|
Academic Article
|
Gallium 67 scans in small cell carcinoma.
|
|
Academic Article
|
Sequential staging in bronchogenic carcinoma.
|
|
Academic Article
|
Small-cell carcinoma of the lung.
|
|
Academic Article
|
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
|
|
Academic Article
|
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
|
|
Academic Article
|
Small-cell carcinoma of the lung: the prognostic significance of stage on survival.
|
|
Academic Article
|
Current concepts in small cell carcinoma of the lung.
|
|
Academic Article
|
Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung.
|
|
Academic Article
|
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience.
|
|
Academic Article
|
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.
|
|
Academic Article
|
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
|
|
Academic Article
|
Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease.
|
|
Academic Article
|
VP16-213 in combined modality treatment of small cell carcinoma of the lung.
|
|
Academic Article
|
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival.
|
|
Academic Article
|
Non-small cell carcinoma of the lung.
|
|
Academic Article
|
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy.
|
|
Academic Article
|
Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
|
|
Academic Article
|
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
|
|
Academic Article
|
Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations.
|
|
Academic Article
|
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
|
|
Academic Article
|
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
|